Body composition test in heart attack patients
Part of Heart & circulation, Hormones & metabolism, Pain clinical trials.
This trial looks at how a simple, painless test called bioelectrical impedance analysis can measure your body's water, fat, and muscle. It may help doctors understand how these factors affect recovery from a heart attack or unstable angina.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized in a cardiovascular care unit.
- You have been diagnosed with acute coronary syndrome (heart attack or unstable angina).
- You are willing to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a simple test called bioelectrical impedance analysis (BIA) to estimate muscle and fat in adults with obesity, comparing it to a more precise scan (DXA). It aims to see if BIA can reliably measure body composition.
This study looks at fluid levels and body composition after heart surgery using a safe, painless device called bioelectrical impedance. It aims to help doctors better manage fluids during recovery.
This study uses a simple, painless test (bio-electrical impedance) to measure body composition in women with functional dyspepsia (stomach discomfort without a clear cause). It aims to better understand how body makeup relates to symptoms.
This study checks how well different body composition measurements work. It may help improve methods used to assess body fat and muscle.
This study looks at blood test “markers” soon after an acute heart attack, to better understand heart damage and whether heart failure is present. It may help doctors improve how they monitor recovery and risk in people after a heart attack.
This trial looks at how body composition (like muscle and fat) relates to stroke in the early days. It involves a brain MRI and simple assessments to understand more about your health.
Hear when a new Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.